Cargando…
MPO-ANCA-associated vasculitis after the Pfizer/BioNTech SARS-CoV-2 vaccination
Vaccination against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has demonstrated high efficacy at preventing coronavirus disease 2019 (COVID-19) and a favorable safety profile, however it has also been reported that COVID-19 vaccines may put increase of immune-mediated disease. We h...
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Oxford University Press
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8500057/ https://www.ncbi.nlm.nih.gov/pubmed/35140936 http://dx.doi.org/10.1093/ckj/sfab181 |